![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61P 11/12 | (2006.01) | ||
A61K 31/4985 | (2006.01) |
(11) | Number of the document | 3544981 |
(13) | Kind of document | T |
(96) | European patent application number | 17807900.0 |
Date of filing the European patent application | 2017-11-22 | |
(97) | Date of publication of the European application | 2019-10-02 |
(45) | Date of publication and mention of the grant of the patent | 2021-06-23 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/GB2017/053499 |
Date | 2017-11-22 |
(87) | Number | WO 2018/096325 |
Date | 2018-05-31 |
(30) | Number | Date | Country code |
201619694 | 2016-11-22 | GB |
(72) |
MCCARTHY, Clive , GB
HARGRAVE, Jonathan, David , GB
HAY, Duncan, Alexander , GB
SCHOFIELD, Thomas, Beauregard , GB
WENT, Naomi , GB
|
(73) |
Enterprise Therapeutics Limited ,
Sussex Innovation Centre
University of Sussex
Science Park Square, Falmer, Brighton BN1 9SB,
GB
|
(54) | BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS |
BENZODIAZOLIUM COMPOUNDS AS ENAC INHIBITORS |